DKK2 and neoplasm: Given that the DKK2 blockade had insignificant effects on tumor angiogenesis at the early stages of tumor progression [12], most of the anti-tumor effects of DKK2 blockade are likely the results of its effects on modulation of tumor immune microenvironments.